Trial Profile
Does Memantine Improve Verbal Memory Task Performance in Subjects With Localization-related Epilepsy and Memory Dysfunction? A Randomized, Double-Blind, Placebo-Controlled Trial
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 13 Jul 2017
Price :
$35
*
At a glance
- Drugs Memantine (Primary)
- Indications Epilepsy; Memory disorders; Temporal-lobe-epilepsy
- Focus Therapeutic Use
- 19 Jan 2017 Status changed from recruiting to completed.
- 23 Nov 2011 Planned End Date changed from 1 Dec 2010 to 1 Dec 2013 as reported by ClinicalTrials.gov.
- 30 Jan 2010 New trial record